16540554

Source:http://linkedlifedata.com/resource/pubmed/id/16540554

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0008976, umls-concept:C0030705, umls-concept:C0036043, umls-concept:C0242708, umls-concept:C0332293, umls-concept:C0443252, umls-concept:C0717758, umls-concept:C0720193
pubmed:issue	12
pubmed:dateCreated	2006-11-19
pubmed:abstractText	To evaluate the long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-10075615, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-10606358, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11096165, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11409115, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11550957, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11762947, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-12115173, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-12794818, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-12949498, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-14156622, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-1485814, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-15001324, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-15829572, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-15996057, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-1976811, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-2509559, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-3970041, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-6722416, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-7540941, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-8147925, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-8507213, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-8945568, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-9219699, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-9811046, http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-9920948
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0003-4967
pubmed:author	pubmed-author:DougadosMM, pubmed-author:Etanercept Study 301 Investigators, pubmed-author:GaubitzMM, pubmed-author:KlareskogLL, pubmed-author:MalaiseMM, pubmed-author:Rodriguez-ValverdeVV, pubmed-author:WajdulaJJ
pubmed:issnType	Print
pubmed:volume	65
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1578-84
pubmed:dateRevised	2010-9-14
pubmed:meshHeading	pubmed-meshheading:16540554-Antirheumatic Agents, pubmed-meshheading:16540554-Arthritis, Rheumatoid, pubmed-meshheading:16540554-Blood Sedimentation, pubmed-meshheading:16540554-C-Reactive Protein, pubmed-meshheading:16540554-Double-Blind Method, pubmed-meshheading:16540554-Drug Administration Schedule, pubmed-meshheading:16540554-Female, pubmed-meshheading:16540554-Follow-Up Studies, pubmed-meshheading:16540554-Humans, pubmed-meshheading:16540554-Immunoglobulin G, pubmed-meshheading:16540554-Male, pubmed-meshheading:16540554-Middle Aged, pubmed-meshheading:16540554-Neoplasms, pubmed-meshheading:16540554-Opportunistic Infections, pubmed-meshheading:16540554-Receptors, Tumor Necrosis Factor, pubmed-meshheading:16540554-Respiratory Tract Infections, pubmed-meshheading:16540554-Severity of Illness Index, pubmed-meshheading:16540554-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs.
pubmed:affiliation	Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm 17176, Sweden. Lars.Klareskog@medks.ki.se
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study